Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
REVAD
NCT03356353Phase 3Unknown
- Sponsor
- University of Calgary
- Start
- Mar 2018
- Primary completion
- Sep 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of sildenafil in right-sided heart failure, sponsored by University of Calgary. Status: unknown.
02
Drugs
sildenafil
03
Conditions
right-sided heart failure
Beyond the preview
Go deeper on NCT03356353.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03356353.